Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04986709 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PMCF Study in Patients With Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated With E-vita OPEN NEO

Study acronym: NEOS-APAC
StatusActive, Not Recruiting
PhaseNot specified
SponsorJOTEC GmbH
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 8, 2024 (before its estimated October 31, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 100 to confirmed 114
    • Study sites: 1 to 10
    v3
  2. Primary completion date: Aug 31, 2023 to Oct 31, 2024
    • Study completion date: Mar 31, 2026 to Mar 31, 2027
    • Secondary endpoints: details revised at 39 of 42 entries
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
JOTEC GmbH
14 trials monitored
See 1 trial at risk
The NEOS-APAC post-market clinical follow-up study is undertaken to demonstrate the safety and clinical performance of E-vita OPEN NEO in the treatment of aneurysm or dissection in the ascending aorta, aortic arch and descending thoracic aorta.
Trial Details
NCT Number NCT04986709
Lead Sponsor JOTEC GmbH
Conditions
(from sponsor)		 Aortic Dissection, Aortic Aneurysm
Related terms Aortic Aneurysm, Aortic Dissection
Enrollment 114 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov